Role of Dual-Hormone Closed-Loop Delivery System in the Future.
作者信息
Bally Lia, Thabit Hood, Hovorka Roman
机构信息
1 Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge , Cambridge, United Kingdom .
2 Department of Diabetes & Endocrinology, Cambridge University Hospitals NHS Foundation Trust , Cambridge, United Kingdom .
出版信息
Diabetes Technol Ther. 2016 Aug;18(8):452-4. doi: 10.1089/dia.2016.0259. Epub 2016 Aug 8.
PMID:27500812
Abstract
摘要
相似文献
1
Role of Dual-Hormone Closed-Loop Delivery System in the Future.
Diabetes Technol Ther. 2016 Aug;18(8):452-4. doi: 10.1089/dia.2016.0259. Epub 2016 Aug 8.
2
Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps.
Diabetes Technol Ther. 2011 Jul;13(7):695-8. doi: 10.1089/dia.2011.0103. Epub 2011 Jun 13.
3
Outpatient 60-hour day-and-night glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or sensor-augmented pump therapy in adults with type 1 diabetes: An open-label, randomised, crossover, controlled trial.
Diabetes Obes Metab. 2017 May;19(5):713-720. doi: 10.1111/dom.12880. Epub 2017 Mar 8.
4
Implications of Predictive Low-Glucose Management System in Hybrid of Full Closed Loop System.
Diabetes Technol Ther. 2016 Jul;18(7):408-9. doi: 10.1089/dia.2016.0227.
5
Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study.
Basic Clin Pharmacol Toxicol. 2018 Mar;122(3):322-330. doi: 10.1111/bcpt.12907. Epub 2017 Oct 11.
6
Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared With a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial.
Diabetes Care. 2020 Nov;43(11):2721-2729. doi: 10.2337/dc19-2267. Epub 2020 Sep 9.
7
FDA Advisory Panel Votes to Recommend Non-Adjunctive Use of Dexcom G5 Mobile CGM.
Diabetes Technol Ther. 2016 Aug;18(8):512-6. doi: 10.1089/dia.2016.07252.mr. Epub 2016 Jul 29.
8
Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.
CMAJ. 2013 Mar 5;185(4):297-305. doi: 10.1503/cmaj.121265. Epub 2013 Jan 28.
9
Role of Devices in Insulin Delivery.
Diabetes Technol Ther. 2017 Feb;19(2):76-78. doi: 10.1089/dia.2017.0011.
10
Safety of using real-time sensor glucose values for treatment decisions in adolescents with poorly controlled type 1 diabetes mellitus: a pilot study.
Pediatr Diabetes. 2017 Jun;18(4):271-276. doi: 10.1111/pedi.12404. Epub 2016 Jul 20.
Zotero 插件